Aeglea BioTherapeutics

0 followers

‌

Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.

Industries

Biotechnology

Headquarters

Austin, United States

Employees

51-200

Links

Org chart

Russell J. Cox

Chief Executive Officer, Epirium Bio

Russell J. Cox

Collapse

Cortney Caudill

Chief Product Officer

Eric Bradford

Chief Development Officer

Gillian Bubb

Senior Director Clinical Science, Clinical Development. Rare Genetic Disease

Teams

Product Management Team

6 members

Clinical Development Team

3 members

Leadership Team

3 members

Similar companies

Vial

5 followers

Thermo Fisher Scientific

155 followers

BeiGene

19 followers

Cytiva

10 followers

Kippa

53 followers

Pendulum

4 followers

Merck

211 followers

Immunome

2 followers

Inari

1 follower

Lightspeed Venture Partners

33 followers

Crunchbase

17 followers

Explore companies